FDA Inspection 1280587 — Clinical Laboratories of Hawaii, LLP

Clinical Laboratories of Hawaii, LLP — FEI 2972911

The FDA completed an inspection of Clinical Laboratories of Hawaii, LLP on August 21, 2025 in Honolulu, HI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 21, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Honolulu, HI (United States)